Shanghai Medicilon Inc (688202) — Cash Flow Reinvestment Rate
Shanghai Medicilon Inc (688202) has a Cash Flow Reinvestment Rate of 17.76x as of June 2022, reinvesting CN¥169.63 Million (capex CN¥34.63 Million plus investments CN¥135.00 Million) from operating cash flow of CN¥9.55 Million. See 688202 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Medicilon Inc Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Shanghai Medicilon Inc across 8 annual periods. For the full cash flow conversion analysis, see 688202 cash flow conversion.
Annual Cash Flow Reinvestment Rate for Shanghai Medicilon Inc (2016–2025)
Year-by-year capital reinvestment analysis for Shanghai Medicilon Inc. See Shanghai Medicilon Inc (688202) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.02x | CN¥212.85 Million | CN¥105.17 Million | CN¥69.03 Million | ▼ -94.5% |
| 2023 | 36.89x | CN¥1.23 Billion | CN¥33.32 Million | CN¥300.10 Million | ▲ +4155.0% |
| 2021 | 0.87x | CN¥392.71 Million | CN¥452.94 Million | CN¥292.71 Million | ▼ -5.0% |
| 2020 | 0.91x | CN¥189.61 Million | CN¥207.77 Million | CN¥118.72 Million | ▼ -68.4% |
| 2019 | 2.89x | CN¥168.27 Million | CN¥58.30 Million | CN¥97.38 Million | ▲ +51.7% |
| 2018 | 1.90x | CN¥135.26 Million | CN¥71.11 Million | CN¥64.37 Million | ▲ +9.5% |
| 2017 | 1.74x | CN¥129.80 Million | CN¥74.70 Million | CN¥58.91 Million | ▼ -16.1% |
| 2016 | 2.07x | CN¥70.70 Million | CN¥34.13 Million | CN¥39.31 Million | — |